Latest AI and machine learning research in skin cancer for healthcare professionals.
BACKGROUND: Artificial intelligence technology is being widely developed in dermatology. However, there remains a lack of comprehensive data analyzing the diagnostic performance of artificial intelligence in skin cancer. OBJECTIVE: We aimed to evaluate the diagnostic accuracy of artificial intelligence in skin cancer detection. METHODS: MEDLINE, Embase, Cochrane library, Web of Science, and Scopus...
INTRODUCTION: Readily available predictive biomarkers for immune checkpoint inhibitor (ICI) response in advanced melanoma are limited. This study evaluates the predictive value of AI-based histopathology analysis. METHODS: Patients with advanced cutaneous melanoma treated with first-line anti-PD1 ±anti-CTLA4 between 2016 and 2023 across 11 Dutch centers were retrospectively identified using prospe...
Cancer immunotherapy targeting the PD-1/PD-L1 pathway has transformed modern oncology; however, developing small-molecule inhibitors as viable alterna...
BACKGROUND: Cell-cell communication (CCC) mediated by ligand-receptor (L-R) interactions is fundamental to deciphering tissue development and disease ...
BACKGROUND: Predicting pathological response to neoadjuvant chemotherapy combined with immunotherapy (NACI) in locally advanced gastric cancer (LAGC) ...
The identification of reliable predictors for immunotherapy response remains a critical challenge in precision oncology. Here, we integrated patient c...
BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is a highly heterogeneous malignancy with poor prognosis and variable response to therapy. E...
PURPOSE: Radiation pneumonitis (RP) is a dose-limiting toxicity in lung cancer radiotherapy, often poorly predicted by static clinical and dosimetric ...
PURPOSE OF REVIEW: To provide an updated overview of the role of the human microbiome in the initiation, progression, and therapeutic response of gast...
Language models (LMs) offer promise for automating concept extraction, a task traditionally reliant on manual curation and earlier natural language pr...
BACKGROUND: Cancer is a leading cause of death in both the USA and India. During Prime Minister Narendra Modi's State Visit to Washington, DC in June ...
Inherited genetic variation can weaken the ability of the immune system to detect and eliminate malignant cells, limiting the effectiveness of cancer ...
Immune checkpoint inhibitors (ICIs) represent a class of novel anticancer agents that enhance T cell-mediated recognition and elimination of tumor cel...
Among adoptive immune cell therapies, cytokine-induced killer cell (CIK) therapy has demonstrated clear therapeutic relevance in multiple cancers, par...
Per- and polyfluoroalkyl substances (PFAS) are persistent pollutants linked to breast cancer (BC), but their role in perineural invasion (PNI) of trip...
Biomarker research for cancer diagnosis and prognosis has rapidly expanded technologically and thematically, along with advancements in molecular diag...
BACKGROUND: Advanced and recurrent cervical cancer (CC) remains a clinical challenge due to limited therapeutic options and a poor 5-year survival rat...
BACKGROUND: Melanoma is the fifth most common cancer in the USA and the UK, with global incidence on the rise. The TNM staging system guides treatment...
Breast cancer is highly heterogeneous,and different molecular subtypes exhibit significant variations in their response to immunotherapy.While signifi...
Colorectal cancer (CRC) is a health burden due to its high mortality rate, recurrence rate, and drug resistance. The limitations of traditional method...